The ATLANTIC trial does not support the safety of prehospital ticagrelor treatment for patients with ST-elevation myocardial infarction.
Sahlgrenska University Hospital, Department of Cardiology, Blå stråket 5, 413 45 Gothenburg, Sweden.
Björn
B
Redfors
Sahlgrenska University Hospital, Department of Cardiology, Blå stråket 5, 413 45 Gothenburg, Sweden.
Oskar
O
Angerås
Sahlgrenska University Hospital, Department of Cardiology, Blå stråket 5, 413 45 Gothenburg, Sweden.
Petur
P
Petursson
Sahlgrenska University Hospital, Department of Cardiology, Blå stråket 5, 413 45 Gothenburg, Sweden.
Truls
T
Råmunddal
Sahlgrenska University Hospital, Department of Cardiology, Blå stråket 5, 413 45 Gothenburg, Sweden. Electronic address: elmir@wlab.gu.se.
Elmir
E
Omerovic
D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic / Q000379:methods; D004632:Emergency Medical Services / Q000379:methods*; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D000077486:Ticagrelor; D016896:Treatment Outcome
D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine
Pre-hospital treatment; Primary percutaneous coronary intervention; ST-elevation myocardial infarction; Ticagrelor